Smileyscope

• 05/10/2023
• Seed
• Undisclosed Amount

Smileyscope is a multi-award winning digital therapeutics company with proprietary technology that reframes medical procedures using choreographed virtual-reality (VR) experiences to help reduce patient pain and anxiety, and improve the overall patient experience. Our vision is to expand the frontiers of patient-centered care, improving the moments that matter most.

Smileyscope VR is the first regulatory body approved VR product for medical use and is clinically proven to reduce patient pain, anxiety and the need for restraints. It is being used by clinicians across a range of medical procedures such as needle procedures, wound dressings, anaesthetic induction, using nitrous oxide, awaiting theatre, and plaster cast applications/removals.

Smileyscope VR has been designed by clinicians, for clinicians. It is very easy to learn and fits seamlessly into the clinical workflow. It has been incredibly well received by clinicians, patients and caregivers.

“It’s a game changer. Patients are getting better care and needing less sedation and pain medication” - Anaesthetist

“My child has had over 300 procedures. This was the first time he has not cried” - Parent of a 5yr old patient

“Smileyscope brings out the joy in work. It can turn a traumatic procedure into a pleasant one” – Emergency Paediatrician

Smileyscope is operating in Australia, USA, UAE, Europe and UK. Smileyscope VR is being used in leading hospitals in Australia, USA and UAE.

For non-USA based queries, please contact info@smileyscope.com to learn more.
For USA based queries, please contact sales@smileyscope.com to learn more.

---

---